97-1987. Proposed Rule to Prohibit Animal Proteins From Ruminants and Minks From Use in Ruminant Feed; Notice of Open Public Forums  

  • [Federal Register Volume 62, Number 17 (Monday, January 27, 1997)]
    [Proposed Rules]
    [Pages 3847-3848]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-1987]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 589
    
    [Docket No. 96N-0135]
    RIN 0901-AA91
    
    
    Proposed Rule to Prohibit Animal Proteins From Ruminants and 
    Minks From Use in Ruminant Feed; Notice of Open Public Forums
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice of public forum.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing two open 
    public forums to discuss the
    
    [[Page 3848]]
    
    notice of proposed rulemaking that provides that animal protein derived 
    from ruminant and mink tissues is not generally recognized as safe for 
    use in ruminant feeds and is a food additive under the Federal Food, 
    Drug, and Cosmetic Act. As such, without a food additive regulation or 
    an exemption, its use in ruminant feeds would be prohibited. While the 
    proposed rule is a preventive measure, the public forums are not 
    preventive measures. Issuance of the proposed rule is part of a series 
    of preventive measures that the agency has taken to protect animals 
    from transmissible degenerative neurological diseases and to minimize 
    any potential risk that such diseases could be transmitted from animal 
    to humans. The agency's proposal and related policy issues will be 
    discussed at the forums. The forums are intended to provide an 
    opportunity for comments from industry and consumers.
    
    DATES: The public forums are scheduled as follows:
    1. Tuesday, February 4, 1997, from 1 p.m. to 4 p.m., St. Louis, MO.
     2. Thursday, February 13, 1997, from 9 a.m. to 12 m., Washington, DC.
    
    ADDRESSES: The open public forums will be held at the following 
    locations:
        St. Louis--Henry VIII Hotel and Conference Center, 4690 North 
    Lindbergh Blvd., St. Louis, MO, 314-731-3040.
        Washington--Holiday Inn--Capitol, 550 C St. SW., Washington, DC, 
    202-479-4000.
    
    FOR FURTHER INFORMATION CONTACT:
        Regarding the St. Louis, MO, open public forum: Charles M. Breen, 
    Office of Regulatory Affairs (HFR-SW400), Food and Drug Administration, 
    12 Sunnen Dr., suite 122, St. Louis, MO 63143, 314-645-1167, FAX 314-
    645-2969.
        Regarding the Washington, DC, open public forum: Susan Mackie, 
    Office of Consumer Affairs (HFE-3), Food and Drug Administration, 5600 
    Fishers Lane, Rockville, MD 20857, 301-827-4407, FAX 301-443-9767.
        Those persons interested in attending the St. Louis, MO, open 
    public forum, should register by faxing their name(s), firm name/
    affiliation, address, telephone and facsimile numbers to Charles M. 
    Breen at 314-645-2969, or send a request for registration by mail to 
    Charles Breen (address above).
        Those persons interested in attending the Washington, DC, open 
    public forum, should register by calling Susan Mackie at 301-827-4407 
    or by faxing or mailing their name(s), firm name/affiliation, address, 
    telephone and facsimile numbers to Susan Mackie (address above).
    
        Persons unable to attend this open public forum, or those who wish 
    to submit their questions or comments in advance of this open public 
    forum, should submit them to the appropriate contact person listed 
    above.
        There is no registration fee for these open public forums. However, 
    due to space limitations, preregistration is required and early 
    registration is recommended.
    SUPPLEMENTARY INFORMATION: In the Federal Register of January 3, 1997 
    (62 FR 552), FDA published a notice of proposed rulemaking that would 
    prohibit using rendered animal protein from mink and from ruminants, 
    animals such as cows, sheep, and goats, in the manufacture of ruminant 
    feeds. FDA will hold two open public forums to discuss its proposal, 
    which is the latest in a series of preventive measures, including a 
    voluntary industry moratorium, that FDA, other Federal agencies, and 
    industry have taken to protect animals from transmissible degenerative 
    neurological diseases and to minimize any potential risk that such 
    diseases could be transmitted from animals to humans. These animal 
    diseases are known as transmissible spongiform encephalopathies 
    (TSE's). Bovine spongiform encephalopathy (BSE) is among the more 
    commonly known of these diseases.
        FDA's proposed regulation would prohibit the use of rendered 
    ruminant and mink proteins in feed intended for ruminants. In addition 
    to prohibiting products with the potential to spread TSE's, the 
    proposed rule also requires process and control systems to ensure that 
    ruminant feed does not contain the prohibited tissues.
        The agency's proposal and related policy issues will be discussed 
    at the forums. The forums are intended to provide an opportunity for 
    feedback and comments from industry and consumers.
        The St. Louis, MO, open public forum is intended primarily to 
    discuss the interests of renderers, animal feed manufacturers, and 
    feedlot operators. The agency will be prepared to consider questions 
    related to the economic assessment. The Washington, DC, open public 
    forum is intended primarily to discuss the interests of consumers and 
    the general public.
        Full transcripts of each open public forum will be made. The 
    transcripts will be incorporated into the administrative record of the 
    proposed rule and placed on file in the public docket (Docket No. 96N-
    0135) for the proposal.
        Persons submitting comments or (questions) at the open public 
    forums are encouraged to submit their comments in advance in writing. 
    Such comments will be placed in the public docket for the proposed rule 
    and presented at the open public forums. Persons unable to attend the 
    forums are also encouraged to submit comments on the proposal to the 
    public docket, and any such questions or comments submitted in advance 
    will be presented at the forums.
        Persons making comments at the forums should limit their remarks to 
    a few minutes and if possible to fewer than 5 minutes to encourage 
    dialogue during the forum and to permit as many people as possible to 
    participate. Persons may submit expanded versions of their oral 
    comments in writing to the public docket.
    
        Dated: January 22, 1997.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 97-1987 Filed 1-23-97; 11:31 am]
    BILLING CODE 4160-01-F